Vaccination strategies, public health impact and cost-effectiveness of dengue vaccine TAK-003: A modeling case study in Thailand
TAK-003 can considerably reduce dengue burden and lead to cost savings in Thailand. These benefits can be maximized by identifying optimal age cohorts for vaccination and adding catch-up programs. Our model can be used to assess the vaccination impact in other dengue-endemic countries.
Authors
- Riona Hanley (ORCID: https://orcid.org/0000-0001-8675-1363)
- Derek Wallace
- Rosarin Sruamsiri (ORCID: https://orcid.org/0000-0002-1437-2492)
- Supattra Rungmaitree (ORCID: https://orcid.org/0000-0001-9439-9152)
- Justyna Zawieja
- Shibadas Biswal (ORCID: https://orcid.org/0000-0001-5077-4838)
- Jing Shen (ORCID: https://orcid.org/0000-0001-8450-5003)
- Samuel Aballéa (ORCID: https://orcid.org/0000-0002-6037-2039)
- Anna Tytula
- Mayuri Sharma (ORCID: https://orcid.org/0000-0003-3118-4343)
- E. Kharitonova
Institutions
- Siriraj Hospital (TH)
- Mahidol University (TH)
- University of Agriculture in Krakow (PL)
- Takeda (Switzerland) (CH)
- Exact Sciences (United States) (US)
- Takeda (United States) (US)
Publication Details
- Journal
- PLoS Medicine
- Published
- 2025-06-17
- DOI
- https://doi.org/10.1371/journal.pmed.1004631
- Citations
- 3
- Primary Topic
- Mosquito-borne diseases and control
- Type
- article
- Field-Weighted Citation Impact
- 5.64
Funders
- Takeda Pharmaceuticals International